Evidence map›Paper›PMID 42500129›Full record

ReviewFrontiers in endocrinology2026

Obesity and bone health: reconciling the density-fragility paradox.

Riad Sulimani

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Riad SulimaniDepartment of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between obesity and bone health is increasingly recognized as complex and paradoxical. Despite higher bone mineral density (BMD) in individuals with obesity, fracture risk is not uniformly reduced. Instead, fractures tend to occur more frequently at peripheral sites such as the ankle, humerus, and tibia, indicating a mismatch between BMD and true bone strength. In the early stages of weight gain, mechanical loading and adipose-derived hormonal factors may promote bone formation. However, these effects are progressively counterbalanced by chronic inflammation, oxidative stress, and marrow adiposity, which impair bone quality and compromise microarchitecture. Conventional dual-energy X-ray absorptiometry (DXA), while central to clinical assessment, cannot capture these changes and may overestimate skeletal strength in the presence of excess soft tissue. Emerging tools such as trabecular bone score and high-resolution peripheral quantitative computed tomography provide additional insights into bone quality, including microarchitecture and cortical porosity, particularly in individuals with type 2 diabetes. Obesity is also associated with vitamin D deficiency, impaired muscle function, and sarcopenic phenotypes, further increasing fracture risk. Bariatric surgery introduces additional challenges by accelerating bone turnover and loss. This review highlights the need to move beyond BMD alone and adopt comprehensive, individualized approaches to fracture risk assessment and management in obesity.

Indexed as

Bone and BonesBone DensityFractures, BoneObesityAnimalsHumansinflammationobesityosteoporosisoxidative stresssarcopenic adiposity

Identifiers

PMID42500129
PMCPMC13395687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.